Sharps Compliance — Credit Suisse 13th Annual Global Services Conference (March 2011)
20 slides from Sharps Compliance's conference presentation, Mar 14, 2011

Slide 1: Sharps Compliance Corp.
800.772.5657 / www.sharpsinc.com Sharps Compliance Corp. NASDAQ: SMED David P. Tusa Chief Executive Officer and President Diana P. Diaz Vice President and Chief Financial Officer Credit Suisse 13 th Annual Global Services Conference March 14, 2011

Slide 2: Safe Harbor Statement
800.772.5657 / www.sharpsinc.com Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “ forward- looking statements ” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “ believe ” , “ estimate ” , “ anticipate ” , “ projec

Slide 3: Sharps Compliance
800.772.5657 / www.sharpsinc.com Sharps Compliance NASDAQ: SMED¹ Market capitalization² $83.7 million Recent price² $5.62 52-week range² $7.87 - $3.65 Avg. daily trading volume (3 mos.) 131,568 ³ Ownership as of December 31, 2010 ¹ Listed 5/6/09; formerly OTCBB: SCOM ² As of 3/7/11 Total shares outs

Slide 4: Sharps Recovery System Sharps Disposal Legislation for Self-Injectors
Sharps Recovery System™ Sharps Disposal Legislation for Self-Injectors Source: (1) Centers for Disease Control and Prevention ♦ Proposed or enacted legislation that covers 30% of the U.S. population Medical Professional Sharps Recovery System™ Sharps Recovery System™ $1 Billion Unregulated Market Op

Slide 5: TakeAway Recovery Systems Unused Medication Disposal Legislation
TakeAway Recovery™ Systems Unused Medication Disposal Legislation ♦ Proposed or enacted legislation that covers 65% of the U.S. population $1 Billion Market Opportunity ♦ 40% of dispensed medications from 4 billion prescriptions go unused annually ♦ Estimated 200 million pounds of medications go unu

Slide 6: Vertically Integrated Solutions Provider
800.772.5657 / www.sharpsinc.com Vertically Integrated Solutions Provider SharpsTracer™ MedTracer™ Fully integrated including distribution, online tracking, treatment and customer reporting Two distribution facilities: Texas and Georgia Regulatory compliant tracking and documentation system: provide

Slide 7: Key Markets: Retail Pharmacies
Key Markets: Retail Pharmacies ü Drives foot traffic and customer interaction ü Unused medication envelope solution now has a shelf presence in some of the nation’s largest drug chains ü Total Market Opportunity: $40 million (TakeAway envelope only) Sharps Recovery System™ TakeAway Recovery™ System

Slide 8: Key Markets: Professional
800.772.5657 / www.sharpsinc.com Key Markets: Professional Launched inside sales initiative in January 2010 Driving Awareness Recurring Revenue Opportunities Educating the Market ü Estimated 800,000 professional offices across the U.S. ü Regulated industry Sharps Recovery System™ ü Total Market Oppo

Slide 9: Key Markets: Core Government - U.S. Department of Veterans Affairs Pilot Program
Key Markets: Core Government U.S. Department of Veterans Affairs Innovative Pilot Program ♦ Launched February 2010 in four state region ♦ Provides medical waste and unused medication disposal solutions ♦ Program expanded to eight geographic regions due to positive response ♦ Opportunity for strong r

Slide 10: Key Markets: Government Contracts
Key Markets: Government Contracts Sharps Proprietary Medical Waste Management System Opportunity to expand to cover more people and to cover unused medications ♦ Rapid-deployment solution in the event of an emergency ♦ Increasingly recognized part of emergency preparedness program ♦ Full service out

Slide 11: Channels to Market
800.772.5657 / www.sharpsinc.com Channels to Market Increased Brand Awareness Retail Hospitality Assisted living Commercial / Industrial Pharmaceutical Manufacturers Government Managed Care Organizations Dentists Doctors Veterinarians Home Healthcare Pharmacies

Slide 12: Financial Highlights
800.772.5657 / www.sharpsinc.com Financial Highlights

Slide 13: Solid Business Model
800.772.5657 / www.sharpsinc.com Solid Business Model Recurring Revenue Early Market Penetration First Mover Advantage Unique Operating Leverage

Slide 14: Billings by Markets Segment
Billings by Markets Segment FY 2008 Billings $13.2 million

Slide 15: Full-year Results
800.772.5657 / www.sharpsinc.com ($ in millions) Full-year Results Core Revenue $39.2 $17.6 $20.3 Gross Margin Operating Margin Net Income * Excludes special charge of $512 thousand and, for net income, an unusual tax benefit of $1.8 million. ** Excludes special charge of $570 thousand.

Slide 16: Quarterly Performance
800.772.5657 / www.sharpsinc.com Quarterly Performance ($ in millions) Core Revenue Gross Margin Operating Margin Net Income $16.0 $3.6 $4.2 $5.2 $4.6 * Excludes Q1 FY2011 special charge of $570 thousand

Slide 17: Strong Balance Sheet
Strong Balance Sheet Cash and Cash Equivalents $17.8M Shareholder Equity Growth Q2 09 vs. Q2 11 297% Line of Credit $5.0M (As of and for the period ending December 31, 2010) No debt as of 12/31/10

Slide 18: Waste Conversion Process
800.772.5657 / www.sharpsinc.com Waste Conversion Process™ ü No landfills required ü Creates a useful raw material ü Safe - 99.999% sterilized, and completely safe to handle ü Environmentally responsible - reduces carbon footprint ü Facilitates corporate environmental initiatives Patent-pending proc

Slide 19: Investment Highlights
800.772.5657 / www.sharpsinc.com Investment Highlights

Slide 20: Definitions
800.772.5657 / www.sharpsinc.com Definitions • Sharps Recovery System™ (formerly Sharps Disposal by Mail System®) A cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets , and other small quantities of bio hazardous waste. The disposal solution is id
Source: SEC EDGAR · 8-K filed Mar 14, 2011
More decks from Sharps Compliance Corp
Investor Presentation (January 2014)28 slides · Jan 10, 2014
Investor Presentation (January 2012)31 slides · Jan 24, 2012
Barrington Research Growth Conference 201123 slides · Sep 7, 2011
William Blair Emerging Growth Stock Conference 201021 slides · Oct 1, 2010
Investor Presentation (May 2009)22 slides · May 14, 2009
Investor Presentation (July 2007)21 slides · Jul 11, 2007